CD133+ cells in all three sarcoma cell lines similarly overexpressed Nanog, N-cadherin, MMP-2, and MMP-9, and had greater MMP-2 and MMP-9 activity compared with CD133- cells (Supplementary Fig. S2C). The gene discussed is CDH2; the disease is sarcoma.